CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 2
- ScaleRevenue is $2.9B, above the global median of $520.53M
- PositionDebt-to-equity is 4.31×, higher than 95% of its Footwear & Accessories peers (median 0.5×)
- Interpretations6 currently firing — 6
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
3.50%Below 5Y avg (5.26%)
Annual Rate
USD 0.20Paid quarterly
Payout Ratio
68.2%Moderate
Paying Dividends
21 yr
Payback Period
28.8 yr
Last Ex-Dividend
Jun 25, 2026
Last Payment
Jul 8, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
290.44MUSDvs all stocks (USD)
Trailing P/E
27.24xvs Footwear & Accessories peers
Revenue (TTM)
2.90BUSDvs all stocks (USD)
Profit Margin
0.36%vs Footwear & Accessories peers
Beta
1.25xvs all stocks
52-Week Change
95.22%vs all stocks
Forward Annual Dividend Yield
3.50%vs all stocks
Market Capitalization
290.44MUSDvs all stocks (USD)
Enterprise Value
1.47BUSDvs all stocks (USD)
Trailing P/E
27.24xvs Footwear & Accessories peers
Forward P/E
9.82xvs Footwear & Accessories peers
PEG Ratio
-0.2561xPrice to Sales (TTM)
0.1001xvs Footwear & Accessories peers
Price to Book (MRQ)
1.03xvs Footwear & Accessories peers
Enterprise to Revenue
0.5070xvs Footwear & Accessories peers
Enterprise to EBITDA
11.05xvs Footwear & Accessories peers
Gross Margin
45.28%vs Footwear & Accessories peers
Profit Margin
0.36%vs Footwear & Accessories peers
Operating Margin
2.31%vs Footwear & Accessories peers
Return on Assets (TTM)
2.27%vs Footwear & Accessories peers
Return on Equity (TTM)
5.61%vs Footwear & Accessories peers
Revenue (TTM)
2.90BUSDvs all stocks (USD)
Revenue per Share (TTM)
58.47USDUpdated Jul 18, 2026Quarterly Revenue Growth
1.40%vs Footwear & Accessories peers
Gross Profit (TTM)
1.28BUSDvs all stocks (USD)
EBITDA (TTM)
133.82MUSDvs all stocks (USD)
Net Income (TTM)
10.60MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
1.37%vs Footwear & Accessories peers
Operating Cash Flow (TTM)
108.19MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
75.38MUSDvs all stocks (USD)
Forward Annual Dividend Rate
0.2000USDUpdated Jul 18, 2026Forward Annual Dividend Yield
3.50%vs all stocks
Trailing Annual Dividend Rate
0.2000USDUpdated Jul 18, 2026Trailing Annual Dividend Yield
3.50%vs all stocks
5-Year Average Dividend Yield
5.26%vs all stocks
Payout Ratio
68.18%vs Footwear & Accessories peers
Minority Interest (Equity)
5.27MUSDFY2026 · Jan 31, 2026Revenue
2.89BUSDFY2026 · Jan 31, 2026Cost of Goods Sold
1.63BUSDFY2026 · Jan 31, 2026Gross Profit
1.26BUSDFY2026 · Jan 31, 2026Operating Income
41.16MUSDvs all stocks (USD)
Pre-tax Income
2.23MUSDFY2026 · Jan 31, 2026Income Tax Expense
6.96MUSDFY2026 · Jan 31, 2026Net Income
-5.57MUSDFY2026 · Jan 31, 2026EBIT
47.57MUSDFY2026 · Jan 31, 2026EBITDA (Income Statement)
111.07MUSDFY2026 · Jan 31, 2026Other Operating Expenses
1.22BUSDFY2026 · Jan 31, 2026Non-operating Interest Expense
45.34MUSDFY2026 · Jan 31, 2026EPS (Basic)
-0.1700USDFY2026 · Jan 31, 2026EPS (Diluted)
-0.1700USDFY2026 · Jan 31, 2026Basic Shares Outstanding
49.14MSharesFY2026 · Jan 31, 2026Diluted Shares Outstanding
49.14MSharesFY2026 · Jan 31, 2026Net Income from Continuing Operations
-5.57MUSDFY2026 · Jan 31, 2026Minority Interests (P&L)
-2.80MUSDFY2026 · Jan 31, 2026Operating Cash Flow
76.49MUSDFY2026 · Jan 31, 2026Free Cash Flow
44.89MUSDFY2026 · Jan 31, 2026Cash & Cash Equivalents (End of Period)
50.87MUSDFY2026 · Jan 31, 2026Interest Paid
39.08MUSDFY2026 · Jan 31, 2026Starting Profit (CF Statement)
-5.57MUSDFY2026 · Jan 31, 2026Depreciation & Amortization
59.08MUSDFY2026 · Jan 31, 2026Deferred Taxes (CF)
7.44MUSDFY2026 · Jan 31, 2026Stock-based Compensation
18.99MUSDFY2026 · Jan 31, 2026Other Non-cash Items
-93.00KUSDFY2026 · Jan 31, 2026Change in Accounts Receivable (CF)
-8.97MUSDFY2026 · Jan 31, 2026Change in Accounts Payable (CF)
-34.53MUSDFY2026 · Jan 31, 2026Change in Other Assets/Liabilities
40.15MUSDFY2026 · Jan 31, 2026Capital Expenditures
-31.61MUSDFY2026 · Jan 31, 2026Net Acquisitions
0.00USDFY2026 · Jan 31, 2026Other Investing Activity
-1.92MUSDFY2026 · Jan 31, 2026Net Investing Cash Flow
-33.52MUSDFY2026 · Jan 31, 2026Long-term Debt Issuance
0.00USDFY2026 · Jan 31, 2026Long-term Debt Payments
-945.17MUSDFY2026 · Jan 31, 2026Net Short-term Debt Issuance
-51.03MUSDFY2026 · Jan 31, 2026Common Stock Repurchase
0.00USDFY2026 · Jan 31, 2026Common Dividends Paid
-9.65MUSDFY2026 · Jan 31, 2026Other Financing Charges
-5.10MUSDFY2026 · Jan 31, 2026Net Financing Cash Flow
-1.01BUSDFY2026 · Jan 31, 2026Shares Outstanding
50.75MSharesUpdated Jul 18, 2026Float Shares
28.77MSharesUpdated Jul 18, 2026Shares Short
5.47MSharesUpdated Jul 18, 2026Short Ratio
5.71daysvs all stocks
Short % of Shares Outstanding
37.77%vs all stocks
% Held by Insiders
17.57%vs all stocks
% Held by Institutions
87.37%vs all stocks
Total Cash (MRQ)
50.10MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
0.9870USDUpdated Jul 18, 2026Total Debt (MRQ)
1.23BUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
4.31xvs Footwear & Accessories peers
Current Ratio (MRQ)
1.27xvs Footwear & Accessories peers
Book Value per Share (MRQ)
5.54USDUpdated Jul 18, 2026Total Assets
1.95BUSDvs all stocks (USD)
Total Current Assets
708.15MUSDFY2026 · Jan 31, 2026Total Liabilities
1.66BUSDFY2026 · Jan 31, 2026Total Non-current Assets
1.24BUSDFY2026 · Jan 31, 2026Total Non-current Liabilities
1.07BUSDFY2026 · Jan 31, 2026Total Current Liabilities
588.47MUSDFY2026 · Jan 31, 2026Cash & Cash Equivalents
50.87MUSDFY2026 · Jan 31, 2026Accounts Receivable
36.62MUSDFY2026 · Jan 31, 2026Inventory
563.55MUSDFY2026 · Jan 31, 2026Accounts Payable
236.19MUSDFY2026 · Jan 31, 2026Short-term Debt
182.26MUSDFY2026 · Jan 31, 2026Deferred Revenue
40.58MUSDFY2026 · Jan 31, 2026Long-term Debt
1.02BUSDFY2026 · Jan 31, 2026Other Non-current Liabilities
46.61MUSDFY2026 · Jan 31, 2026Common Stock (Book)
1.06BUSDFY2026 · Jan 31, 2026Retained Earnings
59.87MUSDFY2026 · Jan 31, 2026Total Shareholders' Equity
287.76MUSDvs all stocks (USD)
Treasury Stock
833.35MUSDFY2026 · Jan 31, 202652-Week Low
2.55USDUpdated Jul 18, 202652-Week High
9.17USDUpdated Jul 18, 202652-Week Change
95.22%vs all stocks
Beta
1.25xvs all stocks
50-Day MA
6.63USDUpdated Jul 18, 2026200-Day MA
6.12USDUpdated Jul 18, 2026Avg 10-Day Volume
610.57KSharesUpdated Jul 18, 2026Avg 30-Day Volume
845.28KSharesUpdated Jul 18, 2026Diluted EPS (TTM)
0.2100USDUpdated Jul 18, 2026Other Income / Expense
6.42MUSDFY2026 · Jan 31, 20266 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Diagnostic
Elevated ROE With High Debt-to-Equity and Equity Multiplier
Return on equity reads high on a balance sheet carrying a lot of debt against that equity.
Reads
Diagnostic
Depreciation-Heavy Reported Profit
It reports a profit, and much of the gap to cash is depreciation rather than earnings.
Reads
Diagnostic
Earnings Growth With Heavy Accrual Component
It reports a profit, with depreciation heavy in the cash bridge and receivables rising.
Reads
Cumulative Treasury Stock Significant With Elevated ROE And FCF-To-Equity
It has bought back shares for years, and its equity earns more than its industry and yields heavy free cash flow.
Reads
Industry-Benchmarked ROA and Margin Elevated
Returns and margins have sat in the top of its industry across five years.
Reads
Where is this company structurally exposed?
Elevated Leverage on Three Denominators
Debt sits high against its equity, its assets, and its cash flow.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Debt-to-equity is 4.31×, higher than 95% of its Footwear & Accessories peers (median 0.5×)Significant
Debt-to-equity: 4.31Industry median: 0.50Industry P95: 3.10Peers compared: 32.00
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.45Profit Margin: 0.00
Financial Health
Altman Z-Score 1.79: grey zoneSignificant
Altman Z-Score: 1.79
High earnings qualityNotable
Earnings Quality Score: 2.60
Supply Chain
Upstream position: supplies 5 industries, depends on 2Notable
Outgoing: 5.00Incoming: 2.00
Scale
Revenue is $2.9B, above the global median of $520.53MNotable
Revenue (USD): 2,902,112,000Global Median: 520,528,949.311
Levered free cash flow is $75.38M, above the global median of $16.24MNotable
Levered free cash flow (USD): 75,379,872Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
CN Healthy Food Tech Group Corp.
Tier 1ProductionBrand-Compounding ConsumerFlowInterface
Forward Industries, Inc.
Tier 1ProductionBrand-Compounding ConsumerFlowInterface
Gansu Huangtai Wine-Marketing Industry Co., Ltd.
Tier 1ProductionBrand-Compounding ConsumerFlowAttention
Sappe Public Company Limited
Tier 1ProductionBrand-Compounding ConsumerFlowAttention
Profit Cultural & Creative Co., Ltd.
Tier 1ProductionBrand-Compounding ConsumerAttentionInterface
Parag Milk Foods Ltd.
Tier 1ProductionBrand-Compounding ConsumerFlowAttention
Globus Spirits Ltd.
Tier 1ProductionBrand-Compounding ConsumerFlowAttention
Microbio Co., Ltd.
Tier 1ProductionBrand-Compounding ConsumerFlowSenseMaking
Bajaj Hindusthan Sugar Ltd.
Tier 1ProductionBrand-Compounding ConsumerFlowRisk
B&G Foods Inc.
Tier 1ProductionBrand-Compounding ConsumerFlowAttention
Companies that share active interpretations — structural patterns currently present in both stocks.
Xeris Biopharma Holdings, Inc.
5 interpretationsDepreciation-Heavy Reported ProfitIndustry-Benchmarked ROA and Margin ElevatedEarnings Growth With Heavy Accrual ComponentElevated ROE With High Debt-to-Equity and Equity MultiplierElevated Leverage on Three Denominators
Travere Therapeutics Inc.
5 interpretationsDepreciation-Heavy Reported ProfitIndustry-Benchmarked ROA and Margin ElevatedEarnings Growth With Heavy Accrual ComponentElevated ROE With High Debt-to-Equity and Equity MultiplierElevated Leverage on Three Denominators
Avery Dennison Corporation
4 interpretationsCumulative Treasury Stock Significant With Elevated ROE And FCF-To-EquityIndustry-Benchmarked ROA and Margin ElevatedElevated ROE With High Debt-to-Equity and Equity MultiplierElevated Leverage on Three Denominators